IDO1 and plexiform neurofibroma: The natural progression of the neurofibromas to a stage of advanced immune evasion, evidenced by co-expression of IDO1 and PD-L1, indicates that porcine NF1 models may be an ideal platform for the study of the biology of neurofibroma advancement and the development of therapies that effectively combine checkpoint inhibitors.